Jun 21–24, 2027 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers:
Cesar de la Fuente, James J. Collins, and Ewa Szczurek
-
Scientific Organizers: Cesar de la Fuente, James J. Collins, and Ewa Szczurek
Cesar de la Fuente, PhD
University of Pennsylvania
James J. Collins, PhD
Broad Institute of MIT & Harvard
Ewa Szczurek, PhD
Helmholtz Munich
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Monday, June 21, 2027
Tuesday, June 22, 2027
The Future of Antibiotic Resistance
Novel Inhibitors against Gram-negative Pathogens
Antibiotic Discovery and Development at GSK
AI Approaches for Antibiotic Discovery
Accelerating Antibiotic Discovery Using AI
Controllable Generative AI for Antimicrobial Peptides Discovery
Wednesday, June 23, 2027
The Natural History of Antibiotic Resistance
Predictive Biology: Understanding and Reversing the Evolution of Antibiotic Resistance
Antibiotic Discovery in Soil
Proteasome-Derived Defense Peptides (PDDPs): An Untapped Source of Antimicrobial Agents
Production of Encrypted Antibiotics in Human Kidney Infections
Thursday, June 24, 2027
Phage Therapy to Combat Infections by Antibiotic-Resistant Bacterial Pathogens
Vaccines against AMR
Anti-Infective Approaches against TB
Peptide Dual Targeting of Membrane and Ribosomes disrupts biofilm formation and prevents in vivo dissemination
Harnessing Iron Acquisition Machinery to Target Pathogens
Anti-Virulence Approaches to Target Pathogens
The Promises and Challenges of Programmable RNA Antibiotics
Machine Learning for Antimicrobial Peptide Design and Discovery
Self-Assembling Peptide Design with Generative AI
Friday, June 25, 2027
Subscribe for Updates